106 Recruiting Triple Negative Breast Cancer Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Triple Negative Breast Cancer
Related Conditions
Top Recruiting Triple Negative Breast Cancer Studies
Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer
📍 Arizona Oncology Associates, PC-Hope,1845 W Orange Grove Rd — Tucson, Arizona
View Study & Checklist ➔Comparison of the Breast Tumor Microenvironment
📍 Columbia University Irving Medical Center — New York, New York
View Study & Checklist ➔Phase 2 Trial of Neoadjuvant Weekly Carboplatin Plus Paclitaxel in Triple Negative Breast Cancer
📍 University of Illinois — Chicago, Illinois
View Study & Checklist ➔Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo
📍 University of South Alabama Mitchell Cancer Institute — Mobile, Alabama
View Study & Checklist ➔Ribociclib and Bicalutamide in AR+ TNBC
📍 University of Illinois Cancer Center — Chicago, Illinois
View Study & Checklist ➔Study of Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With Globo H Positive TNBC
📍 Moores UCSD Cancer Center — La Jolla, California
View Study & Checklist ➔Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD)
📍 Sibley Memorial Hospital — Washington D.C., District of Columbia
View Study & Checklist ➔Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer
📍 Alaska Oncology and Hematology — Anchorage, Alaska
View Study & Checklist ➔Preoperative Lenvatinib Plus Pembrolizumab in Early-Stage Triple-Negative Breast Cancer (TNBC)
📍 University of Illinois — Chicago, Illinois
View Study & Checklist ➔A Phase I Study of Niraparib Administered Concurrently With Postoperative RT in Triple Negative Breast Cancer Patients
📍 Massachusetts General Hospital Cancer Center — Boston, Massachusetts
View Study & Checklist ➔Patterns of Care and Outcomes in Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer
📍 Research Site — Basking Ridge, New Jersey
View Study & Checklist ➔Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC
📍 The University of Kansas Cancer Center - Clinical Research Center — Fairway, Kansas
View Study & Checklist ➔PVX-410 Vaccine Plus Pembrolizumab in HLA-A2+ Metastatic Triple Negative Breast Cancer
📍 Massachusetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔Standard of Care Chemotherapy Plus Pembrolizumab for Breast Cancer
📍 Cedars-Sinai Medical Center — Los Angeles, California
View Study & Checklist ➔Gemcitabine vs Paclitaxel in Caribbean Women of African Ancestry With Metastatic Triple-Negative Breast Cancer
📍 The Queen Elizabeth Hospital — Bridgetown, Saint Michael
View Study & Checklist ➔Personalized Cancer Vaccine (PCV) Strategy in Triple Negative Breast Cancer Patients
📍 Washington University School of Medicine — St Louis, Missouri
View Study & Checklist ➔Blood and imagE-guided Optimization of Neoadjuvant Therapy in People With Early Stage Triple-negative Breast cancER - the BETTER Trial
📍 MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Study of the TheraBionic P1 Device in Patients With Metastatic Triple Negative Breast Cancer After Progression
📍 Karmanos Cancer Institute — Detroit, Michigan
View Study & Checklist ➔ctDNA Positive Patients Diagnosed With cT1bN0 and cT1cN0 TNBC
📍 UPMC Hillman Cancer — Pittsburgh, Pennsylvania
View Study & Checklist ➔NeoCARD: Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Triple-Negative Breast Cancer Patients
📍 Medical University of South Carolina — Charleston, South Carolina
View Study & Checklist ➔Breast Cancer PSMA PET
📍 University of Iowa Healthcare — Iowa City, Iowa
View Study & Checklist ➔PET Dynamics to Response-Adapted Neoadjuvant Therapy in TNBC
📍 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins — Baltimore, Maryland
View Study & Checklist ➔Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients
📍 Wake Forest Baptist Health Sciences — Winston-Salem, North Carolina
View Study & Checklist ➔A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
📍 California Research Institute — Los Angeles, California
View Study & Checklist ➔A Study of Tetrathiomolybdate (TM) Plus Capecitabine
📍 Indiana University Simon Cancer Center — Indianapolis, Indiana
View Study & Checklist ➔ProAgio in Combination With Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer
📍 Emory University Winship Cancer Institute — Atlanta, Georgia
View Study & Checklist ➔A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients
📍 Columbus Regional Research Institute, LLC — Columbus, Georgia
View Study & Checklist ➔Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
📍 Alabama Oncology — Birmingham, Alabama
View Study & Checklist ➔A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
📍 Mayo Clinic Comprehensive Cancer Center — Phoenix, Arizona
View Study & Checklist ➔A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
📍 Dren Investigational Site — Denver, Colorado
View Study & Checklist ➔Monitoring Breast Cancer Immunotherapy Treatment With Advanced Positron Emission Tomography Magnetic Resonance Imaging (PET/MRI)
📍 UAB — Birmingham, Alabama
View Study & Checklist ➔Lifestyle, Exercise, And Nutrition (LEAN) Trial on Pathologic Complete Response in TNBC
📍 Yale University — New Haven, Connecticut
View Study & Checklist ➔A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs
📍 City of Hope — Duarte, California
View Study & Checklist ➔A2-ESO-1 TCR-Engineered T Cells for Relapsed/Refractory Advanced or Metastatic NY-ESO-1 Overexpression Positive Triple Negative Breast Cancer
📍 USC / Norris Comprehensive Cancer Center — Los Angeles, California
View Study & Checklist ➔Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
📍 Natera, Inc. (Data and Specimen Analysis Only) — San Carlos, California
View Study & Checklist ➔DecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast Cancer
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies
📍 University of Maryland Greenebaum Comprehensive Cancer Center — Baltimore, Maryland
View Study & Checklist ➔Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer
📍 Morton Plant Hospital - Baycare Health System — Clearwater, Florida
View Study & Checklist ➔Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer
📍 Stanford University — Stanford, California
View Study & Checklist ➔Study of Screening Brain MRIs in Stage IV Breast Cancer
📍 Morton Plant Mease- Baycare — Clearwater, Florida
View Study & Checklist ➔